Posted in | Antibodies

Building the perfect antibody-based therapeutic from selection to engineering and manufacturing

In this webinar, discover how advanced techniques such as Al-driven candidate selection optimization of antibody sequences, and precise conjugation methods come together to address some of the current challenges in antibody-based therapeutics.

Some things you’ll learn include:

  • Antibody Engineering with Zymeworks: Learn about how we push the boundary of antibody engineering by optimizing antibody sequences to develop the next generation of antibody-based therapeutics, including antibody-drug conjugates.
  • Strategic Al-based Antibody Selection with Aureka Bio: Learn about how Al can accelerate the selection, synthesis, and characterization of antibody candidates at scale during therapeutic discovery.
  • Precision in Antibody Conjugation with ACROBiosystems: Discover how ACROBiosystems can transform your antibodies into antibody-drug conjugates with various life science tools to conjugate and characterize your ADC.

Guest speaker

Linglan Fu, Ph.D.

Associate Scientist
Zymeworks

Eason Lin, Ph.D.

Senior Scientist
AurekaBio

Peter Hsueh, Ph.D.

Marketing Product Manager
ACROBiosystems

Organizers

Other Webinars from ACROBiosystems

Life Science Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.